Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Infracoccygeal Botulinum Toxin Injection to Puborectalis for the Treatment of Dyssynergic Defaecation: a Prospective Observational Study

NCT04879524 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT04879524
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04879524 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Infracoccygeal Botulinum Toxin Injection to Puborectalis for the Treatment of Dyssynergic Defaecation: a Prospective Observational Study
Lead sponsor
Queen Mary University of London
Phase
Observational
Overall status
Completed
Start date
August 6, 2021
Completion date
December 20, 2022
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anismus, defecation disorder, dyssynergic defaecation, evacuation disorder